Crispr Therapeutics shares owned by WealthPlan Investment Management
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by WealthPlan Investment Management
from 13F filings
Historical chart of WealthPlan Investment Management investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by WealthPlan Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Crispr Therapeutics by WealthPlan Investment Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $605k | 9.7k | 62.60 |
2023-09-30 | $426k | 9.4k | 45.39 |
2023-06-30 | $40k | 717 | 56.14 |
2023-03-31 | $400k | 8.9k | 45.23 |
2022-12-31 | $389k | 7.5k | 51.51 |
2022-09-30 | $377k | 7.4k | 50.67 |
2022-03-31 | $382k | 7.7k | 49.62 |
More positions owned by WealthPlan Investment Management
View all positions for WealthPlan Investment Management